TR
Townsend Richard Nolan
CEO
内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Townsend Richard Nolan. Director active across 1 company, notably Lexeo Therapeutics, Inc.. Cumulatively, 23 reports have been published. Split: 0 buy · 8 sells. Total volume traded: €386k. Activity tracked since 5 January 2024. The latest transaction was disclosed on 18 August 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Townsend Richard Nolan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报23 总计
3,345 股@ US$4.95120.0041% mcap2.4% 占其流量Common StockSEC:0001995218-26-000015:0
55,000 股@ US$5.693472.8% 占其流量Common StockSEC:0001995218-26-000009:0
2,623 股@ US$2.6441.5% 占其流量Common StockSEC:0001995218-26-000006:0
10,173 股@ US$6.38211.8% 占其流量Common StockSEC:0001995218-26-000004:0
161,665 股0Common StockSEC:0001995218-26-000002:0
1,127 股@ US$9.272.2% 占其流量Common StockSEC:0001995218-25-000007:0
33,000 股0Common StockSEC:0001995218-25-000005:0
2,193 股@ US$2.6441.2% 占其流量Common StockSEC:0001995218-25-000003:0
1,115 股@ US$4.6681.1% 占其流量Common StockSEC:0001415889-25-024104:0
2,735 股@ US$4.6682.8% 占其流量Common StockSEC:0001415889-25-022473:0
1,074 股@ US$2.7742.6% 占其流量Common StockSEC:0001415889-25-013819:0
2,128 股@ US$2.615.1% 占其流量Common StockSEC:0001415889-25-009450:0
4,326 股@ US$4.41318.0% 占其流量Common StockSEC:0001415889-25-005113:0
103,750 股0Common StockSEC:0001415889-25-001287:0
2,500 股@ US$2.335.5% 占其流量Common StockSEC:0001415889-24-029143:0
2,500 股@ US$2.335.4% 占其流量Common StockSEC:0001415889-24-026737:0
5,000 股@ US$2.3310.5% 占其流量Common StockSEC:0001415889-24-025110:0
5,000 股@ US$2.3310.4% 占其流量Common StockSEC:0001415889-24-023233:0
5,000 股@ US$2.3310.5% 占其流量Common StockSEC:0001415889-24-021245:0
5,000 股@ US$2.3310.6% 占其流量Common StockSEC:0001415889-24-019526:0
5,000 股@ US$2.3310.7% 占其流量Common StockSEC:0001415889-24-016518:0
5,000 股@ US$2.3310.7% 占其流量Common StockSEC:0000950170-24-059506:0
43,750 股0Common StockSEC:0000950170-24-003466:0
About Townsend Richard Nolan
Townsend Richard Nolan is a declarant linked to Lexeo Therapeutics, Inc., where he is Chief Executive Officer. He has 22 filings in total, and among the recent filings tracked, the transactions shown run from 2024-01-09 to 2026-04-07, with 0 in purchases and 371449 in sales, and the most frequent transaction nature is Levée d'options.